Epion Therapeutics Concludes Late-Stage Trials for Keratoconus Therapy

Epion Therapeutics has finished its Phase 3 clinical trials for EpiSmart, a new treatment for keratoconus. The program included two large studies involving around 800 patients across the U.S. The company plans to submit a New Drug Application to the FDA, building on its previous Fast Track designation.